4P-Pharma is a company focusing on preclinical research and specializing in the development of new, innovative and first-in-class medical drugs and therapeutic agents, in the fields of oncology and inflammatory diseases. Our model is based on a co-development, co-share, and co-risk basis. We partner with universities, TTOs, VCs, investors, biotech and pharma companies to translate early stage projects into products.